Literature DB >> 7082306

Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease.

J C Williams, D B Weinstein, A L Miller, D Steinberg.   

Abstract

Skin fibroblast cultures from patients with I-cell disease (mucolipidosis II) are characterized by multiple lysosomal enzyme deficiencies The present studies deal with the consequences of these deficiencies with respect to the metabolism of plasma low-density lipoproteins. Degradation of the protein moiety was defective in I-cells compared with control cells, but the binding and internalization of low density lipoprotein were much less affected. Measurements of low-density lipoprotein degradation in homogenates demonstrated directly for the first time a deficiency of acid proteinase activity in I-cell fibroblasts. Comparison of results in 6-h incubations with those in 24-h incubations showed accumulation of intracellular low-density lipoprotein in I-cell fibroblasts and an accelerating rate of degradation, possibly attributable to intracellular accumulation of low-density lipoprotein substrate. The significance of these findings with respect to low-density lipoprotein metabolism in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082306      PMCID: PMC1158089          DOI: 10.1042/bj2020183

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts.

Authors:  N E Miller; D B Weinstein; T E Carew; T Koschinsky; D Steinberg
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  "I-cell" disease: leakage of lysosomal enzymes into extracellular fluids.

Authors:  U Wiesmann; F Vassella; N Herschkowitz
Journal:  N Engl J Med       Date:  1971-11-04       Impact factor: 91.245

4.  I-cell disease: activities of lysosomal enzymes toward natural and synthetic substrates.

Authors:  D A Wenger; M Sattler; C Clark; C Wharton
Journal:  Life Sci       Date:  1976-08-01       Impact factor: 5.037

5.  Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts.

Authors:  A Hasilik; A Waheed; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

6.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

7.  Binding, internalization, and degradation of low density lipoprotein by normal human fibroblasts and by fibroblasts from a case of homozygous familial hypercholesterolemia.

Authors:  O Stein; D B Weinstein; Y Stein; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

8.  Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts.

Authors:  J G Leroy; J S O'Brien
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

9.  Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.

Authors:  W Gamble; M Vaughan; H S Kruth; J Avigan
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

10.  Acid acylhydrolase deficiency in I-cell disease and pseudo-Hurler polydystrophy.

Authors:  R C Pittman; J C Williams; A L Miller; D Steinberg
Journal:  Biochim Biophys Acta       Date:  1979-12-18
View more
  2 in total

1.  Impaired clearance of free cystine from lysosome-enriched granular fractions of I-cell-disease fibroblasts.

Authors:  F Tietze; L H Rome; J D Butler; G S Harper; W A Gahl
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

2.  Protein catabolism in fibroblasts cultured from patients with mucolipidosis II and other lysosomal disorders.

Authors:  J Kopitz; A Arnold; T Meissner; M Cantz
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.